The Cancer Letter

Inside information on cancer research and drug development

Funding Opportunities

DOD Ovarian Cancer Research Program FY20 funding opportunity

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The FY20 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The FY 2020 Defense Appropriations Bill has not been signed into law—and although FY20 funds have not been appropriated for the Department of Defense Ovarian Cancer Research Program, the OCRP has published information to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunities.

FY20 OCRP program announcements and general application instructions for the following award mechanism is posted on the Grants.gov website.

Table of Contents

YOU MAY BE INTERESTED IN

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report. 
By McKenzie Prillaman
Table of Contents

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account